Kentucky
Kentucky Medicaid has issued a new Standing Order to include at-home COVID-19 tests.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Louisiana
The Department of Health (LDH) Bureau of Health Services Financing announced that effective February 7, 2022, the Medicaid Fee for Service (FFS) Pharmacy Program and Managed Care Organizations (MCOs) will pay for certain COVID-19 oral antiviral agents. Also, on January 26, the Pharmacy Program implemented coverage for OTC at home FDA authorized COVID-19 tests with no copay, with an effective date of January 17, 2022. The fee for service dispensing fee is $10.99.
Also in Louisiana, the Board of Pharmacy’s Regulation Revision Committee approved with no objections the legislative proposal changing the age thresholds in pharmacy immunization law to match age thresholds in PREP Act. Next it will be considered by the full Board at their February 17th meeting in Baton Rouge.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Massachusetts
Massachusetts Medicaid, MassHealth, has released its most recent Fact Sheet to reflect recent modifications in the MassHealth drug lists.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
Missouri
The Department of Social Services MO HealthNet clarified coverage for At-home COVID-19 test kits. Per the PREP Act Declaration 3rd Amendment, pharmacists can prescribe at-home COVID-19 tests that were prescribed by an enrolled MO HealthNet provider for MO HealthNet to reimburse for the at-home COVID-19 test. Pharmacists must be enrolled as a MO HealthNet provider to receive reimbursement.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Nebraska
The Department of Health and Human Services announced the next COVID-19 Medicaid Provider call will take place on February 16 at noon (Central).
Also in Nebraska, prior to a Health and Human Services Committee hearing, NACDS submitted a statement for the record in support of LB 812, legislation that would permit pharmacy technicians to administer vaccines under certain conditions.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Nevada
Since all counties continue to be designated high risk masks are mandatory regardless of vaccination status per Gov. Steve Sisolak’s (D) Directive 045.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
New Hampshire
The New Hampshire Association of Chain Drug Stores testified in strong support for SB (Senate Bill) 229, a proposal which would authorize certified pharmacy technicians to immunize. The Senate Executive Departments and Administration Committee heard no testimony in opposition.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
New York
The State Education Department (SED) has released draft regulations to authorize pharmacists to administer other immunizations to patients 18 years old or older, as recommended by the ACIP (Advisory Committee on Immunization Practices) of the CDC (Centers for Disease Control) (Centers for Disease Control).
Also in New York, The New York State Department of Health has approved the release of January 2022 Medicaid Update. Links to the individual articles are also available below.
All Providers
- New Provider Enrollment Portal Coming Soon to eMedNY (Cover)
- NY State of Health Open Enrollment Period Extended as Federal Public Health Emergency Continues
Policy and Billing
- Update to Fee-for-Service Reimbursement for Federally Qualified Health Center Claims After Third-Party Payers and Managed Care Visit and Revenue Reporting Requirements
- Medicaid Fee-for-Service Guidance for Duchenne Muscular Dystrophy Drugs
- Update to New York State Medicaid Coverage of Real-Time Continuous Glucose Monitors
Pharmacy
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
Ohio
The Board of Pharmacy has proposed a rule to modify the “DUR” requirements outlined in OAR 4729:5-5-08 for gabapentin prescriptions Under the existing rules for DUR, pharmacists are currently required to request and review the OARRS database prior to dispensing certain controlled substances prescriptions. The proposed rule would extend the PDMP review requirement to include certain prescriptions for gabapentin. Pharmacies have been required to report prescriptions for gabapentin to OARRS since 2016. Comments are due before the close of business on February 9 to RuleComments@pharmacy.ohio.gov and CSIPublicComments@governor.ohio.gov.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.